Leustatin and Haemoglobin decreased - a phase IV clinical study of FDA data

Summary:

Haemoglobin decreased is reported as a side effect among people who take Leustatin (cladribine), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Allopurinol, and have Hairy cell leukaemia.

The phase IV clinical study analyzes which people have Haemoglobin decreased when taking Leustatin. It is created by eHealthMe based on reports of 512 people who have side effects when taking Leustatin from the FDA, and is updated regularly.

What is Leustatin?

Leustatin has active ingredients of cladribine. It is often used in high blood cholesterol. eHealthMe is studying from 526 Leustatin users. Check the latest studies of Leustatin.

What is Haemoglobin decreased?

Haemoglobin decreased is found to be associated with 2,408 drugs and 3,129 conditions by eHealthMe. Check the latest studies of Haemoglobin decreased.

On Jul, 14, 2026

512 people reported to have side effects when taking Leustatin.
Among them, 25 people (4.88%) have Haemoglobin decreased.

Could Leustatin cause Haemoglobin decreased?

Among these 25 people:

How long have people been on Leustatin when they have Haemoglobin decreased? *

What is the gender of people who have Haemoglobin decreased when taking Leustatin? *

female: 32 %
male: 68 %

What is the age of people who have Haemoglobin decreased when taking Leustatin? *

What are other drugs people take besides Leustatin? *

Dexamethasone Sodium Phosphate: 5 people, 20.00%
Allopurinol: 5 people, 20.00%
Acetaminophen: 4 people, 16.00%
Diflucan: 4 people, 16.00%
Fluconazole: 4 people, 16.00%
Valtrex: 3 people, 12.00%
Terra-Cortril: 3 people, 12.00%
Rituxan: 3 people, 12.00%
Acyclovir: 3 people, 12.00%
Famotidine: 3 people, 12.00%

What are other side effects people have besides Haemoglobin decreased? *

Thrombocytopenia (decrease of platelets in blood): 19 people, 76.00%
White Blood Cell Count Decreased: 15 people, 60.00%
Blood Albumin Decreased: 10 people, 40.00%
Protein Total Decreased: 10 people, 40.00%
Haematocrit Decreased: 9 people, 36.00%
Alanine Aminotransferase Increased: 8 people, 32.00%
Aspartate Aminotransferase Increased: 8 people, 32.00%
Red Blood Cell Count Decreased: 6 people, 24.00%
Neutrophil Count Decreased (less than normal number of neutrophil a type of blood cell): 6 people, 24.00%
Blood Creatinine Increased: 6 people, 24.00%

What are the existing conditions these people have? *

Hairy Cell Leukaemia (a type of blood cancer): 5 people, 20.00%
Burkitt Lymphoma (cancer of the lymphatic system): 4 people, 16.00%
Constipation: 4 people, 16.00%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 4 people, 16.00%
Herpes Zoster: 3 people, 12.00%
Tumor Lysis Syndrome: 3 people, 12.00%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 2 people, 8.00%
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall): 2 people, 8.00%
Reflux Oesophagitis (an oesophageal mucosal injury that occurs of gastric contents into the oesophagus): 2 people, 8.00%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Leustatin and have Haemoglobin decreased?

- Check whether Haemoglobin decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Leustatin:

Leustatin (526 reports)

Browse all side effects of Leustatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Haemoglobin decreased:

Haemoglobin decreased (2,408 drugs)

Browse all the conditions that are associated with Haemoglobin decreased:

Haemoglobin decreased (3,129 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cladribine (the active ingredients of Leustatin) and Leustatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.